NF-kappa B Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients

dc.contributor.author	Haasbach, Emanuel
dc.contributor.author	Planz, Oliver
dc.date.accessioned	2021-04-14T15:49:14Z
dc.date.available	2021-04-14T15:49:14Z
dc.date.issued	2020
dc.identifier.issn	1664-3224
dc.identifier.uri	http://hdl.handle.net/10900/114297
dc.language.iso	en	en
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fimmu.2020.598444
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	NF-kappa B Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_00167
utue.personen.roh	Kircheis, Ralf
utue.personen.roh	Haasbach, Emanuel
utue.personen.roh	Lueftenegger, Daniel
utue.personen.roh	Heyken, Willm T.
utue.personen.roh	Ocker, Matthias
utue.personen.roh	Planz, Oliver
dcterms.isPartOf.ZSTitelID	Frontiers in Immunology	de_DE
dcterms.isPartOf.ZS-Issue	Article 598444	de_DE
dcterms.isPartOf.ZS-Volume	11	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	Sonstige